MarketLens
Sign Up

What's Behind ARCH Venture Management's Reduced Stake in Maze Therapeutics

5 months ago
SHARE THIS ON:

What's Behind ARCH Venture Management's Reduced Stake in Maze Therapeutics

Exclusive Content for Pro Members

Pro members only. Upgrade to access this article, premium analysis, and stock recommendations.

SHARE THIS ON:

Related Articles

Category

You may also like

Stock News•1 months ago

Standard BioTools Announces Agreement to Sell Microfluidics Business to ARCHIMED

Standard BioTools agreed to sell its Microfluidics business to healthcare investor ARCHIMED, reshaping the company's portfolio. Terms and timing were not disclosed, leaving valuation and proceeds unce...
Stock News•2 months ago

Maze Therapeutics Chief Medical Officer Dumps Entire Direct Stake in the Company for $255,000

Maze Therapeutics CMO Harold Bernstein sold 9,705 shares for ~$255,000 on September 4, 2026, equal to 100% of his directly held common stock before the filing.
Stock News•4 months ago

AstraZeneca's Stock Drops on Wainua's Setback in ATTR-CM Study

AstraZeneca shares fell after Wainua missed the primary endpoint in a late-stage ATTR-CM study, raising doubts about its expansion into a larger market.

Breaking News

View All →

Top Headlines

View More →
Stock News•24 minutes ago

ALPHABET (GOOG) ALERT: Bragar Eagel & Squire, P.C Urgently Reminds Alphabet Inc. Investors to Contact the Firm Seeking Lead Plaintiff Role Before December 1st

Stock News•30 minutes ago

Kaplan Fox & Kilsheimer LLP Alerts NVIDIA Corporation (NVDA) Investors to a Securities Class Action Deadline on January 8, 2027

Stock News•47 minutes ago

GOOGL, GOOG FINAL DEADLINE: ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Alphabet Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - GOOGL, GOOG

Stock News•48 minutes ago

Nvidia's Huang tries to project 'business as usual' in return to office after affair revelation

Stock News•1 hour ago

ALPHABET INC. GOOGL/GOOG Investors with Significant Losses Encouraged to Contact Kirby McInerney LLP About Securities Class Action